Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Influence of Mitroflow bioprosthesis structural valve deterioration on cardiac morbidity

Research output: Contribution to journalJournal articleResearchpeer-review

  1. In-vitro and in-vivo evaluation of a novel bioprosthetic pulmonary valve for use in congenital heart surgery

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Higher arterial pressure during cardiopulmonary bypass may not reduce the risk of acute kidney injury

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Influence of coronary territory on flow profiles of saphenous vein grafts

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Multimodal analgesia versus traditional opiate based analgesia after cardiac surgery, a randomized controlled trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Infants with congenital heart defects have reduced brain volumes

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Exploring patient experiences in the student outpatient clinic - A contribution to learning

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Cardiac Arrhythmias and Impaired Heart Rate Variability in Older Patients With Ventricular Septal Defects

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Lymphatic Function in the Arms of Breast Cancer Patients-A Prospective Cohort Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Farhad Waziri
  • Zarmiga Karunanithi
  • Brian Bridal Løgstrup
  • Vibeke Hjortdal
  • Per Hostrup Nielsen
  • Steen Hvitfeldt Poulsen
View graph of relations

BACKGROUND: This study investigated the extent and nature of cardiac morbidity and cause of mortality in patients with Mitroflow structural valve deterioration (SVD).

METHODS: A retrospective study was performed examining the medical records of patients who had received Mitroflow bioprosthesis between February 2001 and April 2014 and died during this period. A total of 211 patients were identified and included in the analyses. To determine the cause of mortality, cases were divided into three predefined groups: cardiovascular death due to SVD (group 1), cardiovascular death with no SVD (group 2) and non-cardiovascular death without SVD (group 3).

RESULTS: Overall mortality in this study was 7.6% at 1 year, 46.4% at 5 years and 97.2% at 10 years. In group 1, 53 patients (25%) died; in group 2, 59 patients (28%) died; and in group 3, 99 patients (47%) died. Hospitalisation for congestive heart failure was observed in 49.1% in the SVD group vs. 10.2 and 13.1% in the two other groups, p < 0.001. Hospitalisation for endocarditis was also significantly higher in the SVD group (11.3%) than in the two other groups (6.8 and 0%), p < 0.05. Hospitalisation due to myocardial infarction, cerebral stroke, arrhythmia or other cardiac-related diseases was not significantly different between groups.

CONCLUSION: Structural valve deterioration in Mitroflow bioprosthesis was associated with a high prevalence of hospital admissions due to congestive heart failure and endocarditis. Patients with Mitroflow bioprosthesis should be systematically and routinely followed with echocardiography, and reoperation should be considered if SVD has developed.

Original languageEnglish
JournalJournal of Cardiothoracic Surgery
Volume14
Issue number1
Pages (from-to)62
ISSN1749-8090
DOIs
Publication statusPublished - 18 Mar 2019
Externally publishedYes

    Research areas

  • Aged, Aged, 80 and over, Aortic Valve/surgery, Aortic Valve Stenosis/mortality, Bioprosthesis/adverse effects, Echocardiography, Endocarditis/diagnostic imaging, Female, Heart Failure/diagnostic imaging, Heart Valve Prosthesis/adverse effects, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Middle Aged, Morbidity, Prosthesis Failure/adverse effects, Reoperation, Retrospective Studies, Survival Analysis

ID: 59546764